The Democratic vice chair of the U.S. House Energy & Commerce Committee said during a media event yesterday she hopes Congress will address healthcare providers’ concerns about the 340B program during its lame duck session scheduled to end Dec. 15.
At the same event, the Republican who will chair the Energy & Commerce health subcommittee starting Jan. 3 said he hopes Congress during its next session will do more to make hospital prices transparent. He specifically cited as an example the difference between what hospitals pay for 340B-acquired drugs and what they charge private payers for those drugs.
The Democratic vice chair of the U.S. House Energy & Commerce Committee said during a media event yesterday she hopes Congress will address healthcare providers’ concerns about the 340B program during its lame duck session scheduled to end Dec. 15.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
